| Rebecca S Keylor, CRNA | |
|
6520 West Campus Oval, Central Ohio Surgical Institute, New Albany, OH 43054 | |
| (614) 413-2233 | |
| (614) 413-2234 |
| Full Name | Rebecca S Keylor |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Location | 6520 West Campus Oval, New Albany, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346270048 | NPI | - | NPPES |
| 0760458 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | RN153737 (Ohio) | Primary |
| 207L00000X | Anesthesiology | NA03207 (Ohio) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca S Keylor, CRNA Dept L 2312, Doctors Anesthesia Services, Columbus, OH 43260-2312 Ph: (800) 270-2955 | Rebecca S Keylor, CRNA 6520 West Campus Oval, Central Ohio Surgical Institute, New Albany, OH 43054 Ph: (614) 413-2233 |
News Archive
A study from Columbia University reveals that patients, who have been successfully treated with buprenorphine for opioid addiction, are at a greater risk of overdose after completion of the treatment. The study was titled, "Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder", and was published in the latest issue of The American Journal of Psychiatry. This study was funded and supported by the National Institute on Drug Abuse (NIDA) and the Agency for Healthcare Research and Quality.
The development of prediction models that included variables such as pretreatment sexual function, patient characteristics and treatment factors appear to be effective at predicting erectile function 2 years after prostatectomy, external radiotherapy, or brachytherapy for prostate cancer, according to a study in the September 21 issue of JAMA.
Galderma Laboratories, L.P. today announced the U.S. Food and Drug Administration approval of Differin® (adapalene) Lotion, 0.1%, the first-ever lotion formulation of the well-tolerated retinoid adapalene, for the treatment of acne. Differin Lotion, 0.1% will be available by prescription in April 2010.
IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, announced today that it has closed the acquisition of AlliedPath, Inc., a private, early stage high complexity, CLIA-certified laboratory focused on oncology and molecular diagnostics.
› Verified 9 days ago
Dr. Victor Terebuh, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 7333 Smiths Mill Rd, New Albany, OH 43054 Phone: 614-775-6340 Fax: 614-775-5077 | |
Ryan Patrick Mccafferty, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5031 Forest Dr Ste C, New Albany, OH 43054 Phone: 614-939-5416 | |
James L Steen, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6520 West Campus Oval, Central Ohio Surgical Institute, New Albany, OH 43054 Phone: 614-413-2233 Fax: 614-413-2234 | |
Dr. Steven Scott Lechiara, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7333 Smiths Mill Rd, New Albany, OH 43054 Phone: 614-775-6340 | |
Daniel Patrick Pap, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5040 Forest Dr Ste 300, New Albany, OH 43054 Phone: 614-890-6555 Fax: 614-523-7557 | |
Dr. Junaid Mukhdomi, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 5031 Forest Dr Ste C, New Albany, OH 43054 Phone: 614-647-2526 Fax: 877-409-2415 |